Medipharm Labs Corp MEDIF said it applied to upgrade its stock to the Toronto Stock Exchange from the TSX Venture Exchange.
MediPharm is a global extraction, distillation, purification and cannabinoid isolation company. For the last quarter, it reported revenue of $22 million, up by 115% on the year.
Companies listed on larger exchanges are subject to stricter regulations and more scrutiny. It's also easier to attract investors.
Need more cannabis news? Check out all of our coverage here.
With the legalization of cannabis in the U.S. and Canada, more and more companies are feeling confident enough to apply to have their stock listed on a major exchange such as the Toronto Stock Exchange in Canada, or NYSE or NASDAQ in the U.S.
The listing is subject to approval of the Toronto Stock Exchange.
Related Links:
MediPharm Labs Australia Awarded Cannabis Manufacturing License
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!